4DMedical (ASX:4DX) ROCE % : -33.51% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 4DMedical's annualized ROCE % for the quarter that ended in Dec. 2023 was -33.51%.

4DMedical ROCE % Historical Data

The historical data trend for 4DMedical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical ROCE % Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

ROCE %

-22.23

-49.26

-44.28

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			-43.62	-57.52	-57.56	-48.13	-33.51

4DMedical ROCE % Calculation

4DMedical's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-31.13	/	( ( (74.313 - 9.559)	+	(92.924 - 17.072) )	/ 2 )
	=	-31.13	/	( (64.754	+	75.852)	/ 2 )
	=	-31.13	/	70.303
	=	-44.28 %

4DMedical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-31.112	/	( ( (92.924 - 17.072)	+	(143.734 - 33.912) )	/ 2 )
	=	-31.112	/	( ( 75.852	+	109.822 )	/ 2 )
	=	-31.112	/	92.837
	=	-33.51 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

4DMedical (ASX:4DX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

4DMedical ROCE % Related Terms

Thank you for viewing the detailed overview of 4DMedical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines